TRIO Pharmaceuticals, Inc.
PrivateLast Round
Pre Seed
Dec 3, 2024
Total Funding Raised
$5.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company developing a proprietary platform of dual-action tumor immunity-enhancing drugs aimed at treating cancers by targeting specific antigens on cancer cells and immunosuppressor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIO Pharmaceuticals, Inc. Comparables
Compare TRIO Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sidewinder Therapeutics | 83% | |
| Biomunex Pharmaceuticals | 83% | |
| EvolveImmune Therapeutics | 81% |
TRIO Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 3, 2024 | ||||
| Seed | Mar 1, 2023 | ||||
| Grant | Sep 1, 2022 |
TRIO Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Newsight Tech Angels | Seed |
| SeedFolio | Seed |
| TCA Venture Group | Seed |
| Life Science Angels | Seed, Pre Seed |
| Purdue Strategic Ventures | Seed |
| Friedman BioVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 57% MoM, reaching 2.9K.
- Aug 22, 2026
Monthly visitors grew 40% MoM.
TRIO Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TRIO Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is TRIO Pharmaceuticals, Inc. a public or private company?
TRIO Pharmaceuticals, Inc. is a private company.
What is the current stock price of TRIO Pharmaceuticals, Inc.?
TRIO Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks TRIO Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TRIO Pharmaceuticals, Inc. worth (valuation)?
Valuation information for TRIO Pharmaceuticals, Inc. is not publicly available.
Can I buy TRIO Pharmaceuticals, Inc. stock?
TRIO Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TRIO Pharmaceuticals, Inc.'s last funding round?
TRIO Pharmaceuticals, Inc.'s most recent funding round was Pre Seed on December 3, 2024.
Who are the main investors in TRIO Pharmaceuticals, Inc.?
Key investors in TRIO Pharmaceuticals, Inc. include SeedFolio, Friedman BioVentures, NuFund.
Will TRIO Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for TRIO Pharmaceuticals, Inc..
How can I track TRIO Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in TRIO Pharmaceuticals, Inc.'s shares on secondary markets.